Anti-diabetic compounds from Uvaria dulcis Dunal
Medicinal plants have long been a source of lead compounds for drug discovery. Among these, the Annonaceae family has gained recognition for its potential to yield novel compounds, particularly those that can be used in the development of drugs targeting chronic diseases like diabetes mellitus (DM)....
Main Authors: | Passakorn Teerapongpisan, Rachanida Praparatana, Benjaporn Noppradit, Surat Laphookhieo, Panupong Puttarak |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2024-03-01
|
Series: | Heliyon |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2405844024029931 |
Similar Items
-
Flavonoids and Phenols, the Potential Anti-Diabetic Compounds from <i>Bauhinia strychnifolia</i> Craib. Stem.
by: Rachanida Praparatana, et al.
Published: (2022-04-01) -
Inhibitory activity of xanthoangelol isolated from Ashitaba (Angelica keiskei Koidzumi) towards α-glucosidase and dipeptidyl peptidase-IV: in silico and in vitro studies
by: Diah Lia Aulifa, et al.
Published: (2022-05-01) -
Dipeptidyl peptidase IV and its implication in cancer
by: Yarini M Arrebola, et al. -
The complete chloroplast genome of Uvaria macrophylla Roxb. (Annonaceae)
by: Qiaohua Wu, et al.
Published: (2019-07-01) -
Screening for potential novel probiotic Lactobacillus strains based on high dipeptidyl peptidase IV and α-glucosidase inhibitory activity
by: Zhu Zeng, et al.
Published: (2016-01-01)